Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
TwistedSifter on MSN
Emotional doctors reveal new treatment for once incurable brain condition has a 75% success rate
The post Emotional Doctors Reveal New Treatment For Once Incurable Brain Condition Has A 75% Success Rate first on ...
Study Finds on MSN
Childhood Virus Linked To Bladder Cancer Decades Later
A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...
Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...
Researchers at St. Jude built a machine learning model to predict which protein regions drive cancer-linked condensates.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Dallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter. The position represents 2% of Meros’s 13F reportable assets under management.
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...
RRS Sir David Attenborough scientists are trying to measure the potentially crucial role of ocean manganese, finds. But how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback